Navigate Fool.com
Will ONCY beat
the market?
Community Rating: 1 Star: Ominous

1.59 -0.01 (-0.63%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.61
Previous Close $1.60
Daily Range $1.57 - $1.67
52-Week Range $1.40 - $3.50
Market Cap $134.8M
P/E Ratio -6.12
Dividend (Yield) $0.00 (0.0%)
Volume 199,427
Average Daily Volume 538,148
Current FY EPS -$0.30

How do you think ONCY
will perform against the market?

Top ONCY Bull/Bear Pitches


jennings2 (0)
Submitted December 2, 2010

Oncolytics is a speculative play, no doubt. No completed Ph3 yet. It has one drug. A small cap with little cash. So why buy. Simple. Risk reward. ONCY is trying to cure cancer, as are many. Wh … More

0 Replies Reply Report this Post

zzlangerhans (< 20)
Submitted August 9, 2010

If you pay attention to my picks you know not to follow me on a red thumb on a murky cancer biotech with upward momentum. I'm usually right in the long term, but you might have to tolerate a temporary … More

5 Replies Reply Report this Post

News & Commentary Rss Feed

This High-Risk, High-Reward Biotech Is Worth a Look

The cards are certainly stacked against this biotech stock. But if its experimental lead drug proves effective, the sky could be the limit.

Healthcare Stocks Lagging Rest of Market; Oncolytics Biotech Jumps On Positive Data for Cancer Drug

Sector Update: Healthcare

Five Highly Unusual Hot Stocks on the Move for Monday

This Promising Biotech Can Triple

2 Drugs With Acquisition Potential

A New Cancer-Killing Virus

Oncolytics announces successful tests for cancer drug Reolysin.

Can Financial Innovation Unlock a Cure for Cancer?

Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.


2 Biopharmaceuticals With Huge Upside Potential

See More ONCY News...





Oncolytics Biotech, Inc. (USA) (ONCY) Description

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers. Website: http://www.oncolyticsbiotech.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks